|
|
|
Insider
Information: |
Gorlin Steve |
Relationship: |
Director |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
2,272,172 |
|
Indirect Shares
|
6,060,392 |
|
|
Direct
Value |
$849,922 |
|
|
Indirect Value
|
$6,485,361 |
|
|
Total
Shares |
8,332,564 |
|
|
Total
Value |
$7,335,283 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
8
|
2
|
Stock
price went up :
|
8
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
8.0
|
-2.0
|
Percentage
Gain/Loss : |
73.9%
|
-158.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Medivation Inc |
MDVN |
Director, 10% Owner |
|
0 |
2005-06-08 |
2,657,317 |
Premium* |
|
Mimedx Group Inc |
MDXG |
Director |
2013-05-16 |
11,500 |
2013-05-16 |
886,645 |
Premium* |
|
Point Therapeutics Inc |
POTP |
Director |
|
0 |
2008-02-12 |
2,271,330 |
Premium* |
|
Medovex Corp. |
MDVX |
Director within last 9... |
2017-10-30 |
1,640,704 |
2014-12-18 |
125,000 |
Premium* |
|
Ontrak, Inc |
OTRK |
Director |
2015-10-16 |
450,000 |
2018-06-15 |
100,000 |
Premium* |
|
ImmunityBio, Inc |
IBRX |
Director |
2019-06-06 |
92,592 |
2018-11-29 |
0 |
Premium* |
|
PolarityTE, Inc |
PTE |
Director |
2019-08-06 |
31,018 |
|
0 |
Premium* |
|
Biovie Inc. |
BIVI |
Director |
2023-12-01 |
46,358 |
2020-10-15 |
20,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IBRX |
ImmunityBio, Inc |
Director |
|
2018-11-29 |
4 |
S |
$1.70 |
$57,785 |
I/I |
(34,019) |
138,349 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-11-12 |
4 |
S |
$2.43 |
$114,463 |
D/D |
(47,050) |
149,230 |
0 |
- |
|
OTRK |
Ontrak, Inc |
Director |
|
2014-12-22 |
4 |
B |
$2.00 |
$300,000 |
D/D |
150,000 |
150,000 |
2.81 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-11-28 |
4 |
S |
$1.76 |
$30,125 |
I/I |
(17,140) |
172,368 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-11-27 |
4 |
S |
$1.75 |
$175,200 |
I/I |
(100,000) |
189,508 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-08-27 |
4 |
S |
$3.09 |
$56,463 |
D/D |
(18,300) |
196,280 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-08-24 |
4 |
S |
$3.07 |
$31,341 |
D/D |
(10,225) |
214,580 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2015-08-21 |
4 |
S |
$23.00 |
$10,350,000 |
I/I |
(450,000) |
221,720 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-08-23 |
4 |
S |
$3.06 |
$65,709 |
D/D |
(21,475) |
224,805 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2017-09-13 |
4 |
S |
$5.93 |
$234,729 |
D/D |
(39,604) |
246,280 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2017-09-12 |
4 |
S |
$6.03 |
$215,833 |
D/D |
(35,811) |
285,884 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-11-23 |
4 |
S |
$2.01 |
$18,717 |
I/I |
(9,312) |
289,508 |
0 |
- |
|
MDVX |
Medovex Corp. |
|
|
2014-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
292,414 |
|
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-11-21 |
4 |
S |
$2.02 |
$46,217 |
I/I |
(22,900) |
298,820 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2017-09-11 |
4 |
S |
$6.03 |
$321,468 |
D/D |
(53,307) |
321,695 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-06-07 |
4 |
S |
$3.66 |
$98,614 |
I/I |
(26,957) |
321,720 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-06-06 |
4 |
S |
$3.79 |
$89,272 |
I/I |
(23,574) |
348,677 |
0 |
- |
|
MDVX |
Medovex Corp. |
|
|
2015-11-24 |
4 |
B |
$1.45 |
$57,960 |
D/D |
40,000 |
369,462 |
0.01 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-06-05 |
4 |
S |
$3.75 |
$108,339 |
I/I |
(28,925) |
372,251 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2017-09-08 |
4 |
S |
$6.12 |
$90,117 |
D/D |
(14,723) |
375,002 |
0 |
- |
|
MDVX |
Medovex Corp. |
|
|
2015-12-09 |
4 |
B |
$1.15 |
$22,918 |
D/D |
20,000 |
389,462 |
2.39 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2017-06-20 |
4 |
AS |
$7.43 |
$311,200 |
D/D |
(40,000) |
389,725 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-05-30 |
4 |
S |
$3.88 |
$10,564 |
I/I |
(2,724) |
401,176 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-05-29 |
4 |
S |
$3.89 |
$8,175 |
I/I |
(2,100) |
403,900 |
0 |
- |
|
IBRX |
ImmunityBio, Inc |
Director |
|
2018-05-25 |
4 |
S |
$3.97 |
$14,294 |
I/I |
(3,600) |
406,000 |
0 |
- |
|
117 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|